Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hubei Institute of Biopharmaceutical Research is a specialized research and development organization based in Wuhan, China, focused on the advancement of biopharmaceutical technologies. Affiliated with the Hubei Academy of Sciences, the institute primarily engages in the research of natural products, traditional Chinese medicine modernization, and the development of recombinant proteins and vaccines. It serves as a key platform for technology transfer and industrialization within the Hubei province life sciences ecosystem, particularly within the Wuhan Optics Valley Bio-City. The organization provides comprehensive services including drug screening, quality control testing, and pilot-scale production support. Its efforts are aimed at bridging the gap between basic academic research and commercial pharmaceutical manufacturing. The institute also leads several provincial-level innovation alliances to foster regional biotech growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Institute of Biopharmaceutical Research.